Menu
Back to Journals » Drug, Healthcare and Patient Safety » Volume 11
Critical evaluation of the validity of drug promotion materials in Ethiopia
Authors Hailu HG, Gobezie MY, Yesuf TA, Workneh BD
Received 5 January 2019
Accepted for publication 3 June 2019
Published 24 July 2019 Volume 2019:11 Pages 47—54
DOI https://doi.org/10.2147/DHPS.S200487
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Siew Siang Chua
Haftom Gebregergs Hailu,1 Mengistie Yirsaw Gobezie,2 Teshager Aklilu Yesuf,2 Birhanu Demeke Workneh2
1School of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, Ethiopia; 2Department of Pharmacy, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
Purpose: This study was conducted to evaluate the validity of drug promotion materials (DPMs) in Ethiopia.
Methods: A cross sectional document review was done. DPMs were evaluated for fulfilment of the World Health Organization’s (WHO) criteria for ethical promotion of drugs. They were also evaluated for font size, type of formulation, claims made, pictures depicted, retrievability and source of references used.
Results: A total of 235 DPMs were collected from the community and hospital pharmacies. Documents promoting devices and equipment, orthopedic appliances, reminder cards and drug lists were excluded, leaving 173 promotional materials. Antimicrobials were the most promoted drugs (27.2%) followed by respiratory drugs (11.0%) and gastrointestinal drugs (9.8%). Brand name was written in all of the DPMs while approved generic names, indication and active ingredient per dosage form were written in 94.8%, 92.5% and 62.4% respectively. Side effects and contraindications were written in 27.2% and 18.5% of the DPMs. A total of 223 claims were made. Efficacy was the dominant claim (62.3%) followed by safety (8.5%). Pictorial demonstrations were used in 84.4% of the DPMs. Almost half of the pictures depicted, 47.3%, were the cover of the drug products. Only 48.6% of the DPMs has supported their claims with references. Review articles account for 23.3% of the references. Only 5.8% of the journal articles were published after the year 2013.
Conclusion: We conclude that the design and content of studied drug promotional materials are most effective as sales materials rather than thorough informational vehicles. The WHO and Food, Medicine and Health Care Administration and Control Authority of Ethiopia recommendations are rarely met.
Keywords: WHO, drug promotion, ethical drug promotion, promotional information
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.